Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
Phase 2 Unknown
Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus
Phase 1/2 Unknown
50 enrolled
Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
Phase 2 Unknown
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
Phase 1 Unknown
50 enrolled
Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery
Phase 2 Unknown
Erlotinib in Treating Patients With Barrett Esophagus
Phase 1 Unknown
25 enrolled
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
Unknown
14,000 enrolled
Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus
Phase NA Unknown
160 enrolled
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer
Phase NA Unknown
500 enrolled
Studying Genes for Barrett's Esophagus in Brothers and Sisters
Unknown
400 enrolled
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase 2 Unknown
60 enrolled
Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer
Unknown
4,000 enrolled
Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
Phase 3 Unknown
326 enrolled
S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery
Phase 2 Unknown
32 enrolled
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
Phase 4 Unknown
58 enrolled
Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus
Phase 1/2 Unknown
Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus
Phase 2 Unknown
100 enrolled
Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer
Phase 2 Unknown